454 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety and Efficacy of γδ T Cell Against Gastric Cancer
Condition: Gastric Cancer
Interventions: Biological: CIK;   Biological: γδ T;   Biological: CIK and γδ T
22 Recruiting The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
Condition: Gastric Cancer
23 Recruiting The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
Condition: Peptic Ulcer
Interventions: Drug: Lafutidine;   Drug: Irsogladine maleate
24 Not yet recruiting FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer
Conditions: Stomach Cancer;   Gastroesophageal Junction Cancer
Interventions: Drug: FLOT alone;   Biological: FLOT + Herceptin/Pertuzumab
25 Not yet recruiting Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Condition: Gastric Cancer
Interventions: Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Docetaxel;   Drug: Trastuzumab;   Drug: sodium folinate;   Procedure: Surgery
26 Recruiting Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: Quality of life assessment
27 Not yet recruiting Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection
Condition: Gastric Cancer
Intervention: Procedure: Robotic Distal Gastrectomy with D2 LND)
28 Recruiting A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
Condition: Functional Dyspepsia
Interventions: Drug: YH12852 0.1 mg;   Drug: YH12852 0.25 mg;   Drug: YH12852 0.5 mg;   Drug: Placebo
29 Not yet recruiting Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Estrogen Receptor Negative;   Head and Neck Squamous Cell Carcinoma;   HER2/Neu Negative;   Hormone-Resistant Prostate Cancer;   Metastatic Pancreatic Adenocarcinoma;   Progesterone Receptor Negative;   Solid Neoplasm;   Stage III Mesothelioma;   Stage IIIA Gastric Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Small Cell Lung Carcinoma;   Stage IIIB Gastric Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Small Cell Lung Carcinoma;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Small Cell Lung Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib
30 Available Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
Condition: Refractory Gastroesophageal Reflux Disease With Upper Gastrointestinal (GI) Symptoms, Gastroparesis, and Chronic Constipation
Intervention: Drug: Domperidone
31 Recruiting Postoperative Analgesic Effect of Nefopam
Condition: Stomach Neoplasms
Interventions: Drug: Nefopam;   Drug: Saline
32 Not yet recruiting Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Conditions: Helicobacter Pylori Infection;   Family History of Stomach Cancer
Interventions: Drug: Standard triple therapy;   Drug: Bismuth quadruple therapy
33 Recruiting Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
Condition: Gastric Cancer
Interventions: Drug: docetaxel,0xaliplatin,capecitabine;   Drug: oxaliplatin,capecitabine
34 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
35 Recruiting HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
Condition: Gastric Cancer
Intervention: Other: HIPEC,Chemotherapy AND surgery
36 Not yet recruiting Effect of Modified Stylet Angulation on the Intubation With GlideScope®
Conditions: Cholecystitis;   Stomach Cancer
Interventions: Procedure: Glidescope guided intubation;   Device: GlideScope®
37 Recruiting Use of Lidocaine in Endoscopic Submucosal Dissection
Condition: Gastric Neoplasm
Interventions: Drug: Lidocaine 1%;   Drug: Normal saline
38 Recruiting Body Composition After Laparoscopic Gastrectomy for Gastric Cancer
Condition: Gastric Cancer
Intervention: Procedure: Laparoscopic gastrectomy
39 Recruiting Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: apatinib
40 Recruiting Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia
Condition: Gastric Intestinal Metaplasia
Interventions: Drug: lower fluorescein sodium dosage 0.02ml/kg;   Drug: conventional fluorescein sodium dosage 0.1ml/kg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years